Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUCA1 | P04066 | 1/20 | 0.43 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | TAS1R3 | Q7RTX0 | 4/20 | 0.35 |
| ▸ | TAS1R1 | Q7RTX1 | 4/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10151647 | 1.00 | FUCA1 (0.43) | FUCA1EPHX1TSHRNPSR1SMN1; SMN2 | |
| SCHEMBL10151965 | 1.00 | FUCA1 (0.43) | FUCA1EPHX1TSHRNPSR1SMN1; SMN2 | |
| SCHEMBL10069387 | 1.00 | FUCA1 (0.43) | FUCA1EPHX1TSHRNPSR1SMN1; SMN2 | |
| SCHEMBL19817617 | 0.98 | EPHX1 (0.42) | FUCA1EPHX1TSHRNPSR1SMN1; SMN2 | |
| SCHEMBL21232876 | 0.98 | EPHX1 (0.42) | FUCA1EPHX1TSHRNPSR1SMN1; SMN2 | |
| SCHEMBL22170610 | 0.95 | — | — | |
| Alcohol SCHEMBL14109089 | 0.93 | FUCA1 (0.44) | FUCA1EPHX1TSHRNPSR1SMN1; SMN2 | |
| Alcohol SCHEMBL14109615 | 0.91 | EPHX1 (0.43) | FUCA1EPHX1TSHRNPSR1SMN1; SMN2 | |
| Alcohol SCHEMBL14109452 | 0.91 | EPHX1 (0.43) | FUCA1EPHX1TSHRNPSR1SMN1; SMN2 | |
| Propanol SCHEMBL14109491 | 0.89 | FUCA1 (0.41) | FUCA1EPHX1TSHRNPSR1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12559453-B2 | Sulfonic acid-modified polyisocyanate and preparation method therefor | WANHUA CHEMICAL GROUP CO., LTD. (CN) | 2026-02-24 | — | — | US | claimed |
| EP-4144780-B1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | WANHUA CHEMICAL GROUP CO LTD (CN) | 2025-12-24 | — | — | EP | claimed |
| US-20230257344-A1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | WANHUA CHEMICAL GROUP CO., LTD. (CN) | 2023-08-17 | — | — | US | claimed |
| EP-4144780-A1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | Wanhua Chemical Group Co., Ltd. (CN) | 2023-03-08 | — | — | EP | claimed |
| WO-2022257585-A1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | 万华化学集团股份有限公司 | 2022-12-15 | — | — | WO | claimed |
| CN-115466201-A | Sulfonic acid modified polyisocyanate and preparation method thereof | 万华化学集团股份有限公司 | 2022-12-13 | — | — | CN | claimed |
| EP-4144780-B1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | WANHUA CHEMICAL GROUP CO LTD (CN) | 2025-12-24 | — | — | EP | disclosed |
| US-11655371-B2 | Color material dispersion liquid, color resin composition, color filter, liquid crystal display device, and light-emitting display device | DAI NIPPON PRINTING CO., LTD. (JP) | 2023-05-23 | — | — | US | disclosed |
| EP-4144780-A1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | Wanhua Chemical Group Co., Ltd. (CN) | 2023-03-08 | — | — | EP | disclosed |
| WO-2022257585-A1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | 万华化学集团股份有限公司 | 2022-12-15 | — | — | WO | disclosed |
| CN-115466201-A | Sulfonic acid modified polyisocyanate and preparation method thereof | 万华化学集团股份有限公司 | 2022-12-13 | — | — | CN | disclosed |
| CN-109415298-B | Compounds and intermediates thereof | 大日本印刷株式会社 | 2022-03-29 | — | — | CN | disclosed |
| US-20210324200-A1 | COLOR MATERIAL DISPERSION LIQUID, COLOR RESIN COMPOSITION, COLOR FILTER, LIQUID CRYSTAL DISPLAY DEVICE, AND LIGHT-EMITTING DISPLAY DEVICE | DAI NIPPON PRINTING CO., LTD. (JP) | 2021-10-21 | — | — | US | disclosed |
| US-10640456-B2 | Compound and intermediate thereof | DAI NIPPON PRINTING CO., LTD. (JP) | 2020-05-05 | — | — | US | disclosed |
| US-20190308931-A1 | COMPOUND AND INTERMEDIATE THEREOF | DAI NIPPON PRINTING CO., LTD. (JP) | 2019-10-10 | — | — | US | disclosed |
| US-20190218200-A1 | POTASSIUM CHANNEL MODULATORS | NOVARTIS AG (CH) | 2019-07-18 | — | — | US | disclosed |
| US-8211935-B2 | Heterocyclic derivatives for modulation of calcium channels | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2012-07-03 | — | — | US | disclosed |
| US-20110178061-A1 | HETEROCYCLIC DERIVATIVES FOR MODULATION OF CALCIUM CHANNELS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2011-07-21 | — | — | US | disclosed |
| US-20110015173-A1 | PYRROLOPYRIDINE INHIBITORS OF KINASES | ABBOTT LABORATORIES (US) | 2011-01-20 | — | — | US | disclosed |
| US-7569604-B2 | Heterocyclic derivatives for modulation of calcium channels | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2009-08-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190308931-A1 | COMPOUND AND INTERMEDIATE THEREOF | AHR, ARNT, NR1H2 | FUCA1 4487/4885EPHX1 1445/4885TSHR 2157/4885 |
| US-20230257344-A1 | SULFONIC ACID-MODIFIED POLYISOCYANATE AND PREPARATION METHOD THEREFOR | TST, SULT1A1, SULT2A1 | FUCA1 1788/4885EPHX1 4414/4885TSHR 3601/4885 |
| US-20190218200-A1 | POTASSIUM CHANNEL MODULATORS | KCNJ11, KCNJ2, KCNJ1 | FUCA1 2256/4885EPHX1 2639/4885TSHR 2599/4885 |
| US-20110015173-A1 | PYRROLOPYRIDINE INHIBITORS OF KINASES | CDC7, MAP3K7, CDK1 | FUCA1 4060/4885EPHX1 3143/4885TSHR 3466/4885 |
| US-12559453-B2 | Sulfonic acid-modified polyisocyanate and preparation method therefor | TMT1A, SRMS, FTO | FUCA1 3418/4885EPHX1 4673/4885TSHR 1100/4885 |
| US-20110178061-A1 | HETEROCYCLIC DERIVATIVES FOR MODULATION OF CALCIUM CHANNELS | CACNA1D, ORAI1, CACNA1C | FUCA1 4810/4885EPHX1 2430/4885TSHR 4200/4885 |
| US-10640456-B2 | Compound and intermediate thereof | AHR, ARNT, NR1H2 | FUCA1 4487/4885EPHX1 1445/4885TSHR 2157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.